熱門資訊> 正文

Kura Oncology任命Jennifer Fulk为首席财务官

2026-09-08 19:24

Kura Oncology (KURA) on Tuesday announced the appointment of Jennifer Fulk as Chief Financial Officer, effective September 8, 2026.
After more than 15 years at Eli Lilly and Company, Fulk served in a series of senior finance and operating leadership roles, including as CFO of publicly traded Talkspace, COO and CFO of 120Water, and, most recently, CFO of Soleno Therapeutics.
Press release

More on Kura Oncology

Kura Oncology: 'Strong Buy': Ziftomenib AML Expansions With Different Regimens Could Boost KOMZIFTI's Prospects
KURA jumps 9% after CEO purchases 100,000 shares
Kura Oncology rises after hours on large CEO share purchase

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。